Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 152 Breast Neoplasms 40 Prostatic Neoplasms 31 Insulin Resistance 30 Obesity 23 Neoplasms 15 Endometrial Neoplasms 15 Pancreatic Neoplasms 14 Infertility 14 Colorectal Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Anovulation 10 Lung Neoplasms 9 Neoplasm Metastasis 8 Hyperandrogenism 8 Glioblastoma 8 Diabetes Mellitus 8 Squamous Cell Carcinoma of Head and Neck 7 Metabolic Syndrome 7 Melanoma 7 Rectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Head and Neck Neoplasms 5 Brain Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4

Interventions

Ifosfamide 30 Methotrexate 29 Doxorubicin 26 Cyclophosphamide 24 Cisplatin 22 Filgrastim 18 Etoposide 17 Gemcitabine 16 Leucovorin 14 Magnetic Resonance Spectroscopy 11 Temozolomide 10 Specimen Handling 10 cabozantinib 9 apatinib 9 X-Rays 9 Carboplatin 9 fludarabine 8 Radiotherapy 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Drug Therapy 8 Docetaxel 8 Zoledronic Acid 7 Vincristine 7 Sirolimus 7 Phantoms, Imaging 7 Biopsy 7 mifamurtide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Metformin × Clear all

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡